Medicover AB (publ) MCOV-B.ST
Nasdaq Stockholm · Healthcare · Medical Care Facilities
267.00 SEK
+0.9%
2026-11-06
Keep this stock on your watchlist and set email alerts for prices, reports and important announcements where available.
Annual accounts for Medicover
| EUR million | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | 1,510 | 1,746 | 2,092 | 2,378 |
| EBITDA | 216 | 258 | 277 | 377 |
| Net income | 12 | 18 | 17 | 78 |
| Balance sheet | ||||
| Equity | 472 | 496 | 465 | 533 |
| Total debt | 940 | 1,004 | 1,239 | 1,440 |
| Cash | 40 | 51 | 70 | 82 |
| Net debt | 900 | 953 | 1,169 | 1,358 |
| Ratios and per share | ||||
| EBITDA margin | 14.3% | 14.8% | 13.2% | 15.9% |
| Profit margin | 0.8% | 1.0% | 0.8% | 3.3% |
| Return on equity | 2.5% | 3.5% | 3.6% | 14.5% |
| Earnings/share (EUR) | 0.08 | 0.12 | 0.11 | 0.51 |
| Book value/share (EUR) | 3.17 | 3.32 | 3.10 | 3.53 |
| Shares outstanding (M) | 149 | 150 | 150 | 151 |
From the annual statements (Yahoo Finance), in the currency the company reports in. Per-share figures use the shares at the year end. Charts and annual figures →
Key figures
| P/E | 47.2 |
| P/B | 6.9 |
| EV / EBITDA | 13.3 |
| Net debt / EBITDA | 3.6 |
| Return on equity | 14.5% |
| Profit margin | 3.3% |
| Beta 1Y | 0.58 |
| Revenue growth 1Y | +13.7% |
| Revenue CAGR 3Y | +16.3% |
| Earnings/share CAGR 3Y | +86.4% |
| ROE avg. 3Y | 7.2% |
Ratios use the latest annual report that was public 90 days after the year end.
Dividends per share (SEK)
| 2026 | 2.26 |
| 2025 | 1.69 |
| 2024 | 1.35 |
| 2023 | 1.35 |
| 2022 | 1.35 |
Not investment advice. Figures may contain errors from the data source.